TSC
PAVM icon

Two Seas Capital’s PAVmed PAVM Stock Holding History

Two Seas Capital’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.68M Buy
+461,539
New +$4.37M 0.07% 41

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Two Seas Capital's PAVM Position: Q1 2026 in Review

Two Seas Capital opened a new position in PAVmed (PAVM) in Q1 2026: 461,539 shares worth $4.68M. The stake represents 0.07% of the portfolio and ranks #41 among its holdings.

20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Two Seas Capital held 461,539 shares of PAVmed worth $4.68M as of Q1 2026.
  • PAVmed was a new Two Seas Capital position in Q1 2026.
  • PAVmed made up 0.07% of Two Seas Capital's portfolio in Q1 2026, its #41 holding.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Two Seas Capital's 13F filing for Q1 2026, filed 15 May 2026.